ALUNBRIG® (brigatinib) Prescribing Information

ALUNBRIG® (brigatinib) Expert Opinion Video Series: Initiating patients on ALUNBRIG

Dr Brian Clark

Prescribing information is available at the top of the page.

Listen to Dr Brian Clark share his experience of initiating ALUNBRIG in patients with ALK+ aNSCLC to gain insight that can be translated into your own clinical practice. 

Dr Clark discusses the recommended ALUNBRIG dosing regimen, and highlights the availability of the starter pack and provision of the patient alert card for your patients with ALK+ aNSCLC.

 

ALK, anaplastic lymphoma kinase; ALK+, ALK-positive; aNSCLC, advanced non-small cell lung cancer.        

To enjoy the full experience of OncoConnect, including the ability to like and bookmark content for easy access via your account section, please register or login now.